Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
- 1
Wegovy maker Novo sharpens consumer focus with board role for Mars CEO - 2Ancient Pompeii construction site reveals the process for creating Roman concrete
- 3Hypothermia claims newborn in Gaza and more babies are at risk, doctor says
- 4Parents who delay baby's first vaccines also likely to skip measles shots
- 5Best Amusement Park in Asia: Which One Is a Must-Visit
- Tech Devices 2023: The Most blazing Arrivals of the Year
- Surveys of Music Collections by Film Stars
- Nature: 10 High priority Setting up camp Spots In Europe
- Colombia's military rescues 6 siblings who hid in the rainforest to escape from a rebel group
- Scientists Just Discovered Japan’s First New Bird Species in Over 40 Years
- First foreign troop in new gang suppression force lands in Haiti to replace previous mission
- The Incomparable Advanced cameras: Which One Will Win?
- Releasing Learning Experiences: A Survey of the \Learning Made Fun\ Instructive Application
- Egypt seeks to calm tourist fears over fallout of Iran war
